🎁 Black Friday: 50% off Unlimited and 30% off Pro annual plans
Maxigen Biotech Inc. (TPE:1783)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
31.80
-2.00 (-5.92%)
Nov 20, 2026, 1:30 PM CST

Maxigen Biotech Statistics

Total Valuation

Maxigen Biotech has a market cap or net worth of TWD 2.85 billion. The enterprise value is 2.09 billion.

Market Cap2.85B
Enterprise Value 2.09B

Important Dates

The next estimated earnings date is Friday, March 12, 2027.

Earnings Date Mar 12, 2027
Ex-Dividend Date Sep 1, 2026

Share Statistics

Maxigen Biotech has 89.70 million shares outstanding. The number of shares has increased by 0.39% in one year.

Current Share Class 89.70M
Shares Outstanding 89.70M
Shares Change (YoY) +0.39%
Shares Change (QoQ) +0.40%
Owned by Insiders (%) 0.92%
Owned by Institutions (%) 2.04%
Float 42.14M

Valuation Ratios

The trailing PE ratio is 9.49.

PE Ratio 9.49
Forward PE n/a
PS Ratio 3.33
PB Ratio 1.82
P/TBV Ratio 1.82
P/FCF Ratio 12.70
P/OCF Ratio 9.56
PEG Ratio n/a
Financial Ratio History

Enterprise Valuation

The stock's EV/EBITDA ratio is 6.52, with an EV/FCF ratio of 9.30.

EV / Earnings 6.89
EV / Sales 2.44
EV / EBITDA 6.52
EV / EBIT 7.42
EV / FCF 9.30

Financial Position

The company has a current ratio of 5.04, with zero debt.

Current Ratio 5.04
Quick Ratio 4.47
Debt / Equity n/a
Debt / EBITDA n/a
Debt / FCF n/a
Interest Coverage 907.65

Financial Efficiency

Return on equity (ROE) is 19.95% and return on invested capital (ROIC) is 36.64%.

Return on Equity (ROE) 19.95%
Return on Assets (ROA) 10.13%
Return on Invested Capital (ROIC) 36.64%
Return on Capital Employed (ROCE) 17.95%
Weighted Average Cost of Capital (WACC) 6.57%
Revenue Per Employee n/a
Profits Per Employee n/a
Employee Count n/a
Asset Turnover 0.49
Inventory Turnover 2.87

Taxes

In the past 12 months, Maxigen Biotech has paid 29.07 million in taxes.

Income Tax 29.07M
Effective Tax Rate 8.75%

Stock Price Statistics

The stock price has decreased by -25.53% in the last 52 weeks. The beta is 0.42, so Maxigen Biotech's price volatility has been lower than the market average.

Beta (5Y) 0.42
52-Week Price Change -25.53%
50-Day Moving Average 36.38
200-Day Moving Average 39.97
Relative Strength Index (RSI) 23.13
Average Volume (20 Days) 83,512

Short Selling Information

Short Interest n/a
Short Previous Month n/a
Short % of Shares Out n/a
Short % of Float n/a
Short Ratio (days to cover) n/a

Income Statement

In the last 12 months, Maxigen Biotech had revenue of TWD 856.96 million and earned 303.01 million in profits. Earnings per share was 3.35.

Revenue856.96M
Gross Profit 608.85M
Operating Income 281.37M
Pretax Income 332.08M
Net Income 303.01M
EBITDA 319.98M
EBIT 281.37M
Earnings Per Share (EPS) 3.35
Full Income Statement

Balance Sheet

The company has 764.99 million in cash and no debt, with a net cash position of 764.99 million or 8.53 per share.

Cash & Cash Equivalents 764.99M
Total Debt n/a
Net Cash 764.99M
Net Cash Per Share 8.53
Equity (Book Value) 1.56B
Book Value Per Share 17.36
Working Capital 797.06M
Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was 298.38 million and capital expenditures -73.82 million, giving a free cash flow of 224.56 million.

Operating Cash Flow 298.38M
Capital Expenditures -73.82M
Depreciation & Amortization 38.61M
Net Borrowing n/a
Free Cash Flow 224.56M
FCF Per Share 2.50
Full Cash Flow Statement

Margins

Gross margin is 71.05%, with operating and profit margins of 32.83% and 35.36%.

Gross Margin 71.05%
Operating Margin 32.83%
Pretax Margin 38.75%
Profit Margin 35.36%
EBITDA Margin 37.34%
EBIT Margin 32.83%
FCF Margin 26.20%

Dividends & Yields

This stock pays an annual dividend of 2.00, which amounts to a dividend yield of 6.29%.

Dividend Per Share 2.00
Dividend Yield 6.29%
Dividend Growth (YoY) 140.93%
Years of Dividend Growth n/a
Payout Ratio 56.71%
FCF Payout Ratio 79.87%
Buyback Yield -0.39%
Shareholder Yield 5.90%
Earnings Yield 10.53%
FCF Yield 7.87%
Dividend Details

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value
Lynch Upside
Graham Number
Graham Upside
Graham Formula Value
Graham Formula Upside

Stock Splits

The last stock split was on September 7, 2023. It was a forward split with a ratio of 1.05.

Last Split Date Sep 7, 2023
Split Type Forward
Split Ratio 1.05

Scores

Altman Z-Score n/a
Piotroski F-Score 6